One of the posters that Evidências - Kantar Health attended the 21st European Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) highlighted in the TOP 10 ranking. The event was held in Barcelona, Spain from November 10th to 14th and is one of the most importantRead more
Evidências - Kantar Health will participate in the 21st annual European Congress of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) with two posters. The event will be held in Barcelona, Spain from November 10th to 14th and is one of the most important scientific disseminationRead more
The incorporation of drugs to treat patients with rare diseases. This was the theme of the Comitê Executivo do Fórum Nacional do Poder Judiciário. The meeting happened on June 18th at the Conselho Nacional de Justiça (CNJ) in Brasilia (DF). Otávio Clark, CEO of Evidências - Kantar Health, , attendedRead more
To understand the medicines use patterns to treat patients with bipolar disorder type I. This is the aim of the most recent study of Evidências - Kantar Health published in an international journal. The article “Systematic literature review on patterns of pharmacological treatment and adherence amongRead more
We are a hub of healthcare solutions with the objective of solving problems through evidence-based medicine (EBM) techniques and assisting in decision making related to health technologies and market analysis. With strong leadership, our focus is to provide innovative solutions to improve global health by developing high-complexity case analysis, clinical trial design, courses and training, health technology reports, drug registration and incorporation of health technology dossiers, and economic studies. Combining passion for science with great commercial experience and deep knowledge of the Brazilian healthcare ...